While there is a large body of evidence pointing to both Aβ and tau being implicated in AD neuropathology, the extent to which they are causal to the disease or by-products of associated mechanisms is not completely resolved and the subject of heated debates. The gene discussed is MAPT; the disease is Alzheimer disease.